Clinical Trial Update: A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients

View source ↗

Summary

Results from a trial evaluating limited heart monitoring during non-anthracycline trastuzumab-based therapy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-28